Type of Article: Original Research

Volume 5; Issue 8: 2018

Page No.: 721-724

DOI: 10.16965/ijims.2018.132


Ramesh Chandra Vadapalli.

Assistant professor, Department of Orthopaedics, Santhiram Medical College & General Hospital, Nandyal, Kurnool, Andhra Pradesh, India.

Corresponding author: Dr. Ramesh Chandra Vadapalli, Assistant professor, Department of Orthopaedics, Santhiram Medical College & General Hospital, Nandyal, Kurnool, Andhra Pradesh, India. E-Mail: drrameshvadapally@gmail.com


Introduction: Orthopaedicians treats the patients with local injection of corticosteroid (CS) will get the short term pain relief after, not for the long term. Platelet-rich plasma (PRP) injection for lateral epicondylitis (LE) reduces pain and induces healing of the common extensor tendon injury and vascularisation of the diseased tendon. Currently this study evaluates the treatment outcome results of the PRP injection when compared with CS in the treatment of LE.

Materials and Methods: Study was conducted at orthopedic department of Birds hospital, Tirupathi, Chitoor, A. P., with 40 patients of 20 cases in each group, Group A patients were injected with 2 ml of PRP was injected and In Group B 2 ml of methyl prednisolone (40 mg/ml) was injected at the most tender point over the lateral epicondyle of the humerus using the peppering technique and evaluation was carried out to assess the amount of the pain and the amount of disability in the pre-injection phase, and on subsequent consultations at 4 weeks, 12 weeks & 6 months (the final follow up). The pain was assessed by using the Visual Analogue scale (VAS) and the disability was assessed by Nirschl staging.

Results:  Pre-injection, the mean VAS scores for pain and Nirschl stages were similar in group A and group B with P value of 0.74, mean Nirschl stage in group A and group B was 5.84 and 6.05 respectively with P value of 0.45.  There was significant difference between the groups in VAS score (0.56 versus 1.88) and Nirschl stage (0.32 versus 1.84) at 6 months of follow up. At the six-month follow-up 90% patients had complete pain relief in group A in comparison to only 45% in group B. Seven out of 20 (35%) patients had recurrence of pain at 6 months of follow up in group B but none of patients reported recurrence of pain or disability in group A.

Conclusion: PRP appeared to enable biological healing of the lesion, whereas CS appeared to provide short term, symptomatic relief but resulted in tendon degeneration.

Key words: Corticosteroid, Lateral epicondylitis, Platelet-rich plasma, Tennis Elbow.


  1. Allander E. Prevalence, incidence, and remission rates of some common rheumatic diseases or syndromes. Scand J Rheumatol. 1974;3:145–53.
  2. Shiri R, Viikari-Juntura E, Varonen H, Heliovaara M. Prevalence and determinants of lateral and medial epicondylitis: a population study. Am J Epidemiol. 2006;164:1065–74.
  3. Dorf ER, Chhabra AB, Golish SR, McGinty JL, Pannunzio ME. Effect of elbow position on grip strength in the evaluation of lateral epicondylitis. J Hand Surg Am. 2007 Jul-Aug;32(6):882-6.
  4. Labelle H, Guibert R, Joncas J, Newman N, Fallaha M, Rivard CH. Lack of scientific evidence for the treatment of lateral epicondylitis of the elbow. An attempted meta analysis. J Bone Joint Surg Br. 1992 Sep;74(5):646-51.
  5. Eli T. Sayegh BS, Robert J. Strauch MD Does Nonsurgical Treatment Improve Longitudinal Outcomes of Lateral Epicondylitis Over No Treatment? A Meta-analysis. Clin Orthop Relat Res.2015; 473:1093–107 .
  6. Nirschl RP: Tennis elbow tendinosis: pathoanatomy, nonsurgical and surgical management. In Repetitive motion disorders of the upper extremity. Edited by Gordon SL, Blair SJ, Fine LJ. Rosemont, IL: American Academy of Orthopaedic Surgeons.1995:467–79.
  7. Kraushaar BS, Nirschl RP. Tendinosis of the elbow (tennis elbow). Clinical features and findings of histological, immunohistochemical, and electron microscopy studies. J Bone Joint Surg Am.1999;81:259–78.
  8. Ljung BO, Lieber RL, Friden J. Wrist extensor muscle pathology in lateral epicondylitis. J Hand Surg Britain.1999;24:177-83.
  9. Tonks JH, Pai SK, Murali SR: Steroid injection therapy is the best conservative treatment for lateral epicondylitis: a prospective randomised controlled trial. Int J Clin Pract. 2007;61:240–6.
  10. Maffulli N, Longo UG, Denaro V. Novel approaches for the management of tendinopathy. J Bone Joint Surg Am.2010;92:2604–13.
  11. Bisset L, Beller E, Jull G, Brooks P, Darnell R, Vicenzino B. Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ. 2006 Nov 4;333(7575):939.-44.
  12. Smidt N, van der Windt DA, Assendelft WJ, Devillé WL, Korthals-de Bos IB, Bouter LM. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial. Lancet. 2002;359(9307):657-62.
  13. Gandhi A, Dumas C, O’Connor JP, Parsons JR, Lin SS. The effects of local platelet rich plasma delivery on diabetic fracture healing. Bone 2006;38:540–6.
  14. Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg. 2005;16:1043–54.
  15. Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009;17:602–8.
  16. Mishra A, Gosens T. Clinical indications and techniques for the use of platelet-rich plasma in the elbow. Oper Tech Sports Med. 2011;19:170–6.
  17. Wolf JM, Ozer K, Scott F, Gordon MJ, Williams AE. Comparison of autologous blood, corticosteroid, and saline injection in the treatment of lateral epicondylitis: a prospective, randomized, controlled multicenter study. J Hand Surg Am. 2011;36:1269–72.
  18. Nirschl RP. Elbow tendinosis/tennis elbow. Clin Sports Med. 1992;11:851–70.
  19. de Mos M, van der Windt AE, Jahr H, van Schie HT, Weinans H, Verhaar JA, et al. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med. 2008;36:1171–8.
  20. Kajikawa Y, Morihara T, Sakamoto H, Matsuda K, Oshima Y, Yoshida A, et al. Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol.2008;215:837–45.
  21. Lucarelli E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, et al. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials. 2003;24:3095–100.
  22. Kawamura S, Ying L, Kim HJ, Dynybil C, Rodeo SA. Macrophages accumulate in the early phase of tendon-bone healing. J Orthop Res. 2005;23:1425–32.
  23. Woodall J Jr, Tucci M, Mishra A, Asfour A, Benghuzzi H. Cellular effects of platelet rich plasma: interleukin-1 release from PRP treated macrophages. Biomed Sci Instrum. 2008;44:489–94.
  24. Woodall J Jr, Tucci M, Mishra A, Benghuzzi H. Cellular effects of platelet rich plasma: a study on HL-60 macrophage-like cells. Biomed Sci Instrum. 2007;43:266–71.
  25. Mishra A, Collado H, Fredericson M. Platelet-rich plasma compared with corticosteroid injection for chronic lateral elbow tendinosis. PMR. 2009;1:366–70.
  26. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010;38:255–62.
  27. Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med. 2011;39:1200–8.

Download Full Text TOC